Cancer

(Image: Getty/Oatawa)

Almac expands neo-antigen peptide manufacturing

By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.